| 122.3 | H03BB02 | thiamazol | p.o. | 10.00 | MG | 2.83 | ||
| 122.4 | H03BB02 | thiamazol | parent. | 10.00 | MG | 4.50 | H | |
| 122.5 | H03BC01 | perchlorát draselný | p.o. | 0.20 | GM | 1.66 | ||
| 123 | glukagon a homeostatika vápníku a ostatní hormonální léčiva | |||||||
| 123.1 | H04AA01 | glukagon | parent. | 1.00 | MG | 404.62 | L/DIA | |
| 123.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1.00 | MG | 819.51 | L/DIA | |
| 83741 | GLUCAGEN 1 MG HYPOKIT | inj sic 1mg+sol+stŘ | NOO | DK |
| 123.3 | H05AA02 | teriparatid | parent. | 20.00 | RG | 390.00 | X |
| 123.4 | H05BA01 | kalcitonin (lososí) | parent. | 100.00 | U | 118.09 | L/INT,ORT, END,GER |
| 123.5 | H05BA01 | kalcitonin (lososí) | inhal. | 200.00 | U | 61.20 | P |
Kalcitonin předepisuje internista, ortoped, revmatolog, gynekolog a endokrinolog u osteoporózy dokumentované denzitometricky (méně než –2,5 SD) nebo osteoporotické patologické zlomeniny pokud jsou tyto stavy spojené s výrazným algickým (bolestivým) syndromem, nereagujícím na běžnou analgetickou terapii. Po 3.měsících je vyhodnocen efekt léčby. Pokud došlo k ústupu algického syndromu, je možno pokračovat v další léčbě po dobu maximálně 6 měsíců.
| 123.6 | H05BA03 | kalcitonin (lidský, do 50 U v jedné ampuli včetně) | parent. | 100.00 | U | 125.37 | L/INT,ORT, END,GER | ||
| 123.7 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli včetně) | parent. | 100.00 | U | 157.39 | L/INT,ORT, END,GER | ||
| 123.8 | H05BX01 | cinacalcet | p.o. | 60.00 | MG | 392.45 | X | ||
| 124 | ostatní léčiva ze skupiny hormonů | ||||||||
| 124.1 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.50 | MG | 3.42 | |||
| 124.2 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.50 | MG | 4.79 | |||
| 86606 | MEDROL 16 MG | por tblnob50x16mg-b | PPU | B |
| 125 | tetracyklinová a amfenikolová antibiotika | |||||||||
| 125.1 | J01AA02 | doxycyklin | p.o. | 0.10 | GM | 3.92 | ||||
| 04013 | DOXYBENE 200 MG TABLETY | por tbl nob10x200mg | MCK | D |
| 12737 | DOXYHEXAL 200 TABS | tbl 10x200mg | SFS | D |
| 12738 | DOXYHEXAL 200 TABS | tbl 20x200mg | SFS | D |
| 32953 | DOXYHEXAL TABS | tbl 10x100mg | SFS | D |
| 32954 | DOXYHEXAL TABS | tbl 20x100mg | SFS | D |
| 47718 | DOXYCYCLIN AL 100 | tbl 10x100mg | APA | D |
| 47719 | DOXYCYCLIN AL 100 | tbl 20x100mg | APA | D |
| 47720 | DOXYCYCLIN AL 200 | tbl 10x200mg | APA | D |
| 97654 | DOXYBENE 100 MG | cps 10x100mg | MCK | D |
| 125.2 | J01AA02 | doxycyklin | parent. | 0.10 | GM | 91.28 | K | |
| 125.3 | J01AA04 | lymecyklin | p.o. | 0.60 | GM | 3.92 | ||
| 125.4 | J01AA06 | oxytetracyklin | p.o. | 1.00 | GM | 3.92 | ||
| 125.5 | J01AA07 | tetracyklin | p.o. | 1.00 | GM | 3.92 | ||
| 125.6 | J01AA08 | minocyklin | p.o. | 0.20 | GM | 7.84 | ||
| 125.7 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 94.63 | K | |
| 125.8 | J01AA | doxycyklin v kombinaci s ambroxolem | p.o. | 1.00 | DF | 6.17 | ||
| 125.9 | J01BA01 | chloramfenikol | p.o. | 3.00 | GM | 25.88 | ||
| 125.10 | J01BA01 | chloramfenikol | parent. | 3.00 | GM | 267.93 | K | |
| 125.11 | J01BA02 | thiamphenikol | parent. | 1.50 | GM | 176.31 | K | |
| 126 | peniciliny se širokým spektrem, perorální podání | |||||||
| 126.1 | J01CA01 | ampicilin (pevné lékové formy) | p.o. | 2.00 | GM | 14.13 | ||
| 126.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2.00 | GM | 17.20 | ||
| 126.3 | J01CA04 | amoxicilin (pevné lékové formy) do 0,5 gm v 1tabletě včetně | p.o. | 1.00 | GM | 10.10 | ||
| 32557 | OSPAMOX 500 MG | por tbl flm14x500mg | SZK | A |
| 44337 | AMOXIHEXAL 500 | tbl obd 10x500mg | HHC | D |
| 44338 | AMOXIHEXAL 500 | tbl obd 20x500mg | HHC | D |
| 66364 | OSPAMOX 250MG | cps 12x250mg | SZK | A |
| 66368 | OSPAMOX 500 MG | por tbl flm12x500mg | SZK | A |
| 17628 | AMOXIHEXAL 500 | tbl obd 10x500mg | SFS | D |
| 176629 | AMOXIHEXAL 500 | tbl obd 20x500mg | SFS | D |
| 126.4 | J01CA04 | amoxicilin (pevné lékové formy) nad 0,5 gm v 1tabletě | p.o. | 1.00 | GM | 9.06 |
| 17623 | AMOXIHEXAL 1000 | tbl obd 10x1000mg | SFS | D |
| 17624 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | SFS | D |
| 17625 | AMOXIHEXAL 1000 | tbl obd 50x1000mg | SFS | D |
| 17630 | AMOXIHEXAL 750 | tbl obd 10x750mg | SFS | D |
| 17632 | AMOXIHEXAL 750 | tbl obd 50x750mg | SFS | D |
| 32558 | OSPAMOX 750 MG | por tbl flm14x750mg | SZK | A |
| 32559 | OSPAMOX 1000 MG | por tblflm14x1000mg | SZK | A |
| 44339 | AMOXIHEXAL 750 | tbl obd 10x750mg | HHC | D |
| 44341 | AMOXIHEXAL 750 | tbl obd 50x750mg | HHC | D |
| 44342 | AMOXIHEXAL 1000 | tbl obd 10x1000mg | HHC | D |
| 44343 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | HHC | D |
| 44344 | AMOXIHEXAL 1000 | tbl obd 50x1000mg | HHC | D |
| 65929 | AMOXICILLIN AL 1000 | tbl obd 10x1000mg | APA | D |
| 65958 | AMOXICILLIN AL 1000 | tbl obd 20x1000mg | APA | D |
| 66369 | OSPAMOX 750 MG | por tbl flm12x750mg | SZK | A |
| 66370 | OSPAMOX 1000 MG | por tblflm 12x1000mg | SZK | A |
| 126.5 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 gm včetně v 5 mililitrech) | p.o. | 1.00 | GM | 11.67 |
| 17620 | AMOXIHEXAL | plv sus 1x100ml | SFS | D |
| 17622 | AMOXIHEXAL FORTE | plv sus 1x100ml | SFS | D |
| 44345 | AMOXIHEXAL | plv sus 1x100ml | AAG | D |
| 44347 | AMOXIHEXAL FORTE | plv sus 1x100ml | AAG | D |
| 62050 | DUOMOX 500 | tbl 20x500mg | YEU | NL |
| 62053 | DUOMOX 375 | tbl 20x375mg | YEU | NL |
| 66366 | OSPAMOX 250MG/5ML | gra sus 1x60ml | SZK | A |
| 66367 | OSPAMOX 375MG/5ML | gra sus 1x60ml | SZK | A |
| 126.6 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 gm v 5 mililitrech) | p.o. | 1.00 | GM | 10.00 | ||
| 126.7 | J01CA06 | bakampicilin | p.o. | 1.20 | GM | 16.62 | ||
| 127 | peniciliny se širokým spektrem, ostatní cesty aplikace | |||||||
| 127.1 | J01CA01 | ampicilin | parent. | 2.00 | GM | 43.35 | K | |
| 86197 | AMPICILIN 0.5 BIOTIKA | inj sic 50x500mg | BTA | SK |
| 127.2 | J01CA09 | azlocilin | parent. | 12.00 | GM | 637.48 | U/ATB |
| 127.3 | J01CA12 | piperacilin | parent. | 14.00 | GM | 1 297.98 | U/ATB |
| 127.4 | J01CA13 | tikarcilin | parent. | 15.00 | GM | 1 980.92 | U/ATB |
| 127.5 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 2.00 | GM | 162.17 | U/ATB |
| 127.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1.00 | GM | 107.91 | U/ATB |
| 66020 | AUGMENTIN 1.2 GM | inj sic 10x1.2gm | SKW | GB |
| 127.7 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15.00 | GM | 1 792.58 | U/ATB |
| 93169 | TIMENTIN 1.6 GM | inj sic 4x1.6gm | SKW | GB |
| 93170 | TIMENTIN 3.2 GM | inj sic 4x3.2gm | SKW | GB |
| 127.8 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14.00 | GM | 1 980.92 | U/ATB | ||
| 127.9 | J01CR50 | kombinace penicilinů | parent. | 3.00 | DF | 71.80 | U | ||
| 128 | peniciliny citlivé k betalaktamáze, perorální podání | ||||||||
| 128.1 | J01CE02 | fenoxymethylpenicilin ( od 500 KU včetně do 900 KU včetně v jedné tabletě) | p.o. | 2.00 | GM | 17.95 | |||
| 92435 | V-PENICILIN 0.8 MEGA BIOTIKA | por tbl nob30x800ku | BTA | SK |
| 45996 | OSPEN 500 | por tbl film30x500ku | SZK | A |
| 128.2 | J01CE02 | fenoxymethylpenicilin (méně než 500 KU v jedné tabletě) | p.o. | 2.00 | GM | 19.75 | |||
| 92434 | V-PENICILIN 0.4 MEGA BIOTIKA | por tbl nob30x400ku | BTA | SK |
| 128.3 | J01CE02 | fenoxymethylpenicilin (nad 900 KU v jedné tabletě) | p.o. | 2.00 | GM | 16.85 | |||
| 01881 | PENBENE 1 000 000 | tbl obd 21x1mu | MCK | D |
| 45997 | OSPEN 1000 | por tblflm30x1000ku | SZK | A |
| 45998 | OSPEN 1500 | por tblflm30x1500ku | SZK | A |
| 49513 | PENBENE 1 000 000 | tbl obd 30x1mu | MCK | D |
| 57778 | PENBENE 1 500 000 | tbl obd 21 | MCK | D |
| 66359 | OSPEN 1000 | por tblflm12x1000ku | SZK | A |
| 66360 | OSPEN 1500 | por tblflm12x1500ku | SZK | A |
| 92436 | V-PENICILIN 1.2 MEGA BIOTIKA | por tbl nob30x1.2mu | BTA | SK |
| 128.4 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 KU v 5 ml včetně) | p.o. | 2.00 | GM | 69.99 | |||
| 128.5 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy nad 250 KU v 5 ml) | p.o. | 2.00 | GM | 26.30 | |||
| 128.6 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 14.19 | |||
| 128.7 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2.00 | GM | 25.91 | |||
| 129 | peniciliny citlivé k betalaktamáze, ostatní cesty aplikace | ||||||||
| 129.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.60 | GM | 121.29 | K | ||
| 01093 | PENICILIN G 1.0 DRAS.SOL BIOT. | inj sic 10x1mu | BTA | SK |
| 02136 | PENICILIN G 0.5 DRAS.SOL BIOT. | inj sic 10x500ku | BTA | SK |
| 129.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.60 | GM | 49.06 | K | ||
| 129.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2.00 | MU | 70.63 | K | ||
| 129.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2.00 | MU | 26.93 | K | ||
| 129.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2.00 | MU | 79.58 | K | ||
| 129.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2.00 | MU | 38.84 | K | ||
| 129.7 | J01CE30 | kombinace | parent. | 0.50 | DF | 10.31 | K | ||
| 130 | peniciliny rezistentní k betalaktamáze a kombinace penicilinů včetně inhibitorů betalaktamáz, perorální podání | ||||||||
| 130.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2.00 | GM | 28.74 | |||
| 130.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2.00 | GM | 39.98 | |||
| 130.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2.00 | GM | 28.74 | |||
| 130.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2.00 | GM | 39.98 | |||
| 130.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1.00 | GM | 30.20 | |||
| 130.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 1 g v 1 tabletě) | p.o. | 1.00 | GM | 20.63 | |||
| 130.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1.00 | GM | 27.50 | |||
| 130.8 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg do 1 g v 1 tabletě včetně) | p.o. | 1.00 | GM | 25.80 | |||
| 130.9 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1.00 | GM | 39.60 | |||
| 130.10 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1.00 | GM | 30.00 | |||
| 32434 | BETAKLAV | por plv sus1x100ml | KRK | SLO |
| 130.11 | J01CR04 | sultamicilin (pevné lékové formy) | p.o. | 1.50 | GM | 77.18 | |
| 130.12 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.50 | GM | 80.90 | |
| 131 | jiná betalaktamová antibiotika, perorální podání | ||||||||||
| 131.1 | J01DB01 | cefalexin (pevné lékové formy) | p.o. | 2.00 | GM | 38.13 | |||||
| 131.2 | J01DB01 | cefalexin (tekuté lékové formy) | p.o. | 2.00 | GM | 39.53 | |||||
| 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A |
| 131.3 | J01DC02 | cefuroxim axetil (pevné lékové formy) | p.o. | 1.00 | GM | 87.73 | |||
| 131.4 | J01DC02 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1.00 | GM | 134.70 | |||
| 131.5 | J01DC04 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.50 | GM | 57.45 | |||
| 131.6 | J01DC04 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.50 | GM | 53.80 | |||
| 131.7 | J01DC04 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.50 | GM | 84.00 | |||
| 131.8 | J01DC04 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.50 | GM | 70.20 | |||
| 131.9 | J01DB05 | cefadroxil (pevné lékové formy) | p.o. | 2.00 | GM | 38.13 | |||
| 131.10 | J01DB05 | cefadroxil (tekuté lékové formy) | p.o. | 2.00 | GM | 40.92 | |||
| 131.11 | J01DD08 | cefixim | p.o. | 0.40 | GM | 91.00 | ATB | ||
| 131.12 | J01DD10 | cefetamet | p.o. | 1.00 | GM | 91.00 | ATB | ||
| 131.13 | J01DD13 | cefpodoxim | p.o. | 0.40 | GM | 87.73 | ATB | ||
| 131.14 | J01DD14 | ceftibuten | p.o. | 0.40 | GM | 87.73 | ATB | ||
| 131.15 | J01DC10 | cefprozil (pevné lékové formy) | p.o. | 1.00 | GM | 87.73 | |||
| 131.16 | J01DC10 | cefprozil (tekuté lékové formy) | p.o. | 1.00 | GM | 134.70 | |||
| 132 | jiná betalaktamová antibiotika, ostatní cesty aplikace | ||||||||
| 132.1 | J01CF04 | oxacilin | parent. | 2.00 | GM | 95.80 | K | ||
| 132.2 | J01DD62 | cefoperazon a inhibitor beta-laktamázy | parent. | 2.00 | GM | 397.00 | U/ATB | ||
| 132.3 | J01DB03 | cefalotin | parent. | 4.00 | GM | 125.17 | U/ATB | ||
| 132.4 | J01DB04 | cefazolin | parent. | 3.00 | GM | 120.93 | U/ATB | ||
| 02205 | CEFAZOLINE PANPHARMA | inj sic 25x1gm | LPA | F |
| 84018 | CEFAZOLINE PANPHARMA | inj sic 50x1gm | LPA | F |
| 85510 | VULMIZOLIN 1.0 | inj sic 50x1gm | BTA | SK |
| 91148 | VULMIZOLIN 1.0 | inj sic 10x1gm | BTA | SK |
| 132.5 | J01DC01 | cefoxitin | parent. | 6.00 | GM | 937.79 | U/ATB |
| 132.6 | J01DC02 | cefuroxim | parent. | 4.00 | GM | 329.10 | U/ATB |
| 132.7 | J01DC04 | cefamandol | parent. | 6.00 | GM | 575.27 | U/ATB |
| 132.8 | J01DD01 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6.00 | GM | 477.44 | U/ATB |
| 132.9 | J01DD01 | cefotaxim nad 1 g v jedné ampuli | parent. | 6.00 | GM | 440.56 | U/ATB |
| 132.10 | J01DD02 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6.00 | GM | 1 736.18 | U/ATB |
| 132.11 | J01DD02 | ceftazidim nad 500 mg v jedné ampuli | parent. | 6.00 | GM | 1 679.42 | U/ATB |
| 132.12 | J01DD03 | cefsulodin | parent. | 6.00 | GM | 615.68 | U/ATB |
| 132.13 | J01DD04 | ceftriaxon | parent. | 2.00 | GM | 508.60 | ambulantně: K/P ústavně: U/ATB |
Léčbu ceftriaxonem v ambulantní péči ordinuje neurolog, infekcionista, dermatolog, pediatr nebo revmatolog k:
- a) inciální léčbě bakteriální meningitidy u dětí mladších 18 let,
- b) léčbě Lymské boreliózy II. a III. stádium (doložené laboratorním vyšetřením),
- c) léčbě nekomplikované akutní kapavky (jednorázová nitrosvalová aplikace 250 mg ceftriaxonu).
| 132.14 | J01DD07 | ceftizoxim | parent. | 4.00 | GM | 615.68 | U/ATB | ||
| 132.15 | J01DE01 | cefepim | parent. | 4.00 | GM | 1 445.00 | U/ATB | ||
| 132.16 | J01DB08 | cefapirin | parent. | 4.00 | GM | 194.73 | U/ATB | ||
| 132.17 | J01DD12 | cefoperazon | parent. | 6.00 | GM | 1 297.00 | U/ATB | ||
| 132.18 | J01DE02 | cefpirom | parent. | 4.00 | GM | 1 638.40 | U/ATB | ||
| 132.19 | J01DF01 | aztreonam | parent. | 4.00 | GM | 1 645.60 | U/ATB | ||
| 132.20 | J01DH | ertapenem | parent. | 1.00 | GM | 1 885.39 | U/ATB | ||
| 132.21 | J01DH02 | meropenem | parent. | 2.00 | GM | 2 194.52 | U/ATB | ||
| 132.22 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2.00 | GM | 2 238.99 | U/ATB | ||
| 133 | sulfonamidy a trimetoprim | ||||||||
| 133.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.40 | GM | 11.60 | |||
| 89813 | TRIPRIM 100MG | tbl 20x100mg | MCK | D |
| 133.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.40 | GM | 8.94 | |||
| 133.3 | J01EB05 | sulfafurazol | p.o. | 4.00 | GM | 13.64 | |||
| 133.4 | J01EE01 | sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 127.04 | K | ||
| 133.5 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 6.40 | |||
| 133.6 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 17.06 | |||
| 133.7 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22.39 | |||
| 133.8 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6.94 | |||
| 133.9 | J01EE03 | sulfametrol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23.07 | |||
| 133.10 | J01EE04 | sulfamoxol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6.94 | |||
| 133.11 | J01EE04 | sulfamoxol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23.07 | |||
| 133.12 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6.94 | |||
| 134 | makrolidová antibiotika a jejich kombinace s antibakteriálními léčivy | ||||||||
| 134.1 | J01FA | telithromycin | p.o. | 800.00 | MG | 96.80 | U/ATB | ||
| 134.2 | J01FA01 | erythromycin | parent. | 1.00 | GM | 717.50 | K | ||
| 134.3 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1.00 | GM | 19.09 | |||
| 134.4 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1.00 | GM | 33.69 | |||
| 134.5 | J01FA02 | spiramycin | p.o. | 3.00 | GM | 42.75 | |||
| 134.6 | J01FA02 | spiramycin | parent. | 4.50 | MU | 653.19 | K | ||
| 134.7 | J01FA05 | oleandomycin | p.o. | 1.00 | GM | 14.59 | |||
| 134.8 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 38.67 | |||
| 134.9 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.30 | GM | 31.60 | |||
| 10855 | ROXITHROMYCIN-RATIOPHARM 150 MG por tbl flm10x150mg | MCK | D |
| 10857 | ROXITHROMYCIN-RATIOPHARM 150 MG por tbl flm14x150mg | MCK | D |
| 10875 | ROXITHROMYCIN-RATIOPHARM 300 MG por tbl flm10x300mg | MCK | D |
| 134.10 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2.00 | GM | 30.08 | |||
| 134.11 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1.00 | GM | 40.45 | |||
| 134.12 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.50 | GM | 40.01 | |||
| 134.13 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.50 | GM | 66.50 | |||
| 134.14 | J01FA09 | klaritromycin | parent. | 1.00 | GM | 731.80 | K | ||
| 134.15 | J01FA10 | azithromycin (pevné lékové formy) | p.o. | 0.25 | GM | 52.78 | |||
| 134.16 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.25 | GM | 82.27 | |||
| 134.17 | J01FA10 | azitromycin | parent. | 0.50 | GM | 474.33 | K | ||
| 134.18 | J01FA13 | dirythromycin | p.o. | 0.50 | GM | 42.75 | |||
| 134.19 | J01FG02 | quinupristin v kombinaci s dalfopristinem | parent | 1.00 | DF | 2 492.00 | U/ATB | ||
| 134.20 | J01RA | kombinace antibakteriálních léčiv (spiramycin/metronidazol) | p.o. | 5.00 | DF | 32.16 | |||
| 135 | linkosamidová antibiotika | ||||||||
| 135.1 | J01FF01 | klindamycin (do 0,3 gm včetně v jedné ampuli) | parent. | 1.80 | GM | 538.80 | U/ATB | ||
| 135.2 | J01FF01 | klindamycin (nad 0,3 gm v jedné ampuli) | parent. | 1.80 | GM | 494.02 | U/ATB | ||
| 135.3 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.20 | GM | 44.37 | |||
| 135.4 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.20 | GM | 136.53 | |||
| 135.5 | J01FF02 | linkomycin | parent. | 1.80 | GM | 49.17 | U/ATB | ||
| 135.6 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.80 | GM | 29.33 | ATB | ||
| 91997 | NELOREN | cps 16x500mg | LEK | SLO |
| 135.7 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.80 | GM | 160.62 | ATB | |
| 136 | aminoglykosidová antibiotika | |||||||
| 136.1 | J01GA01 | streptomycin | parent. | 1.00 | GM | 117.10 | ||
| 13797 | STREPTOMYCIN 1GM | plv sol 10x1gm/lahv | BAK | BG |
| 136.2 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 43.84 | U/ATB |
| 136.3 | J01GB01 | tobramycin (léková forma – inhalační roztok) | inhal. | 0.60 | GM | 2 975.00 | P |
Tobramycin v inhalační formě je indikován pacientům s cystickou fibrózou infikovaných Pseudomonas aeruginosa, starších 6-ti let.
| 136.4 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23.02 | U/ATB | |
| 136.5 | J01GB03 | gentamicin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 45.18 | U/ATB | |
| 136.6 | J01GB03 | gentamicin (lékové formy kuliček k implantaci) | imp. | 1.00 | DF | 152.06 | U/ATB | |
| 136.7 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130.00 | MG | 2 411.98 | U/ATB | |
| 136.8 | J01GB03 | gentamicin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23.61 | U/ATB | |
| 136.9 | J01GB05 | neomycin | parent. | 1.00 | GM | 122.34 | U/ATB | |
| 136.10 | J01GB06 | amikacin (do 100 mg v jedné ampuli včetně) | parent. | 1.00 | GM | 741.01 | U/ATB | |
| 136.11 | J01GB06 | amikacin (nad 100 mg v jedné ampuli) | parent. | 1.00 | GM | 398.66 | U/ATB | |
| 136.12 | J01GB07 | netilmicin (do 50 mg v jedné ampuli včetně) | parent. | 0.35 | GM | 519.93 | U/ATB | |
| 136.13 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 304.57 | U/ATB | |
| 136.14 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1.00 | GM | 620.27 | U/ATB | |
| 136.15 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1.00 | GM | 516.90 | U/ATB | |
| 137 | chinolonová chemoterapeutika | |||||||
| 137.1 | J01MA | trovafloxacin | p.o. | 0.20 | GM | 24.50 | P | |
K léčbě trovafloxacinem je třeba konzultace a schválení antibiotického střediska.
| 137.2 | J01MA | trovafloxacin | parent. | 0.20 | GM | 212.23 | U/ATB |
| 137.3 | J01MA01 | ofloxacin | p.o. | 0.40 | GM | 19.00 | |
| 12349 | ZANOCIN 200MG | tbl obd 10x200mg | RXY | IND |
| 137.4 | J01MA01 | ofloxacin | parent. | 0.40 | GM | 212.23 | U/ATB |
| 137.5 | J01MA02 | ciprofloxacin | p.o. | 1.00 | GM | 19.00 | |
| 137.6 | J01MA02 | ciprofloxacin – infúze | parent. | 0.50 | GM | 212.23 | U/ATB |
| 137.7 | J01MA02 | ciprofloxacin – injekce | parent. | 0.50 | GM | 186.84 | U/ATB |
| 137.8 | J01MA03 | pefloxacin | p.o. | 0.80 | GM | 19.00 | |
| 137.9 | J01MA03 | pefloxacin | parent. | 0.80 | GM | 93.26 | U/ATB |
| 137.10 | J01MA04 | enoxacin | p.o. | 0.80 | GM | 19.00 | |
| 137.11 | J01MA06 | norfloxacin | p.o. | 0.80 | GM | 19.00 | |
| 137.12 | J01MA07 | lomefloxacin | p.o. | 0.80 | GM | 19.00 | |
| 137.13 | J01MA08 | fleroxacin | p.o. | 0.40 | GM | 19.00 | |
| 137.14 | J01MA08 | fleroxacin | parent. | 0.40 | GM | 212.23 | U/ATB |
| 137.15 | J01MA09 | sparfloxacin | p.o. | 0.20 | GM | 19.00 | P |
K léčbě sparfloxacinem je třeba konzultace a schválení antibiotického střediska.
Následující stránka